Vivos Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vivos Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q3 2024.
  • Vivos Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.13M, a 23% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.13M -$337K -23% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.22M -$327K -21.2% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.3M -$319K -19.7% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.39M -$310K -18.3% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $1.47M -$662K -31.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.54M -$671K -30.3% Jun 30, 2023 10-Q 2023-08-16
Q1 2023 $1.62M +$107K +7.07% Mar 31, 2023 10-Q 2023-06-08
Q4 2022 $1.7M Dec 31, 2022 10-K/A 2024-07-30
Q3 2022 $2.13M Sep 30, 2022 10-Q 2022-12-20
Q2 2022 $2.22M Jun 30, 2022 10-Q 2022-12-20
Q1 2022 $1.51M Mar 31, 2022 10-Q/A 2022-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.